Institute of Cancer Research, United Kingdom: Observational study closed enrollment, 3500 enrolled (Prostate Cancer, BRCA Mutation)
Institute of Cancer Research, United Kingdom: Observational study closed enrollment, 3500 enrolled (Prostate Cancer, BRCA Mutation). Its enrollment of 3,500 is top-decile (98th percentile of 8,879 records). Dated 6 days ago, it is inside the fresh trigger window. Score 65/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 3,500 · 98th percentile of 8,879 ClinicalTrialStartPulse records · 43.8x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Institute of Cancer Research, United Kingdom |
| Sponsor type | Academic and hospital |
| Study | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer |
| NCT ID | NCT00261456 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Prostate Cancer; BRCA Mutation; Mismatch Repair Gene Mutation; Genetic Predisposition to Disease |
| Intervention types | diagnostic test, procedure |
| Target enrollment | 3500 |
| Site countries | United Kingdom |
| Posted | 2005-12-05 |
| Planned start | 2005-03 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-30 |
| Last update posted | 2026-10-30 |
| enrollment percentile | 98th of 8,879 (median 80, 43.8x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Institute of Cancer Research, United Kingdom
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Institute of Cancer Research, United Kingdom + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-30
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Institute of Cancer Research, United Kingdom and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Institute of Cancer Research, United Kingdom's enrollment: 98th percentile of 8,879 records
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
65 / 100 Score
- Posted in the last two weeks.
- Enrollment closed: data management, monitoring and closeout ahead.
- 3500 participants planned.
What is the ClinicalTrialStartPulse record for Institute of Cancer Research, United Kingdom?
Institute of Cancer Research, United Kingdom's Observational study (NCT00261456) in Prostate Cancer, first posted 2005-12-05: enrollment closed (active, not recruiting) (2026-10-30), in an update posted 2026-10-30.
How does Institute of Cancer Research, United Kingdom compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 3,500 is 43.8x the median of 80 across 8,879 records. It is fresh: dated 6 days ago, inside the window where early outreach matters most.
Institute of Cancer Research, United Kingdom vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Institute of Cancer Research, United Kingdom | NONUS | 3,500 | 98th | 2026-10-30 |
| Hoffmann-La Roche | NONUS | 1,800 | 96th | 2026-10-30 |
| Janssen Pharmaceutica N.V., Belgium | NONUS | 1,314 | 95th | 2026-11-03 |
| Teva Branded Pharmaceutical Products R&D LLC | NONUS | 1,085 | 95th | 2026-11-03 |
Related records
- Calyxo, Inc.
- Hoffmann-La Roche
- Restor3D
- Kardium Inc.
- Janssen Biotech, Inc.
- Janssen Scientific Affairs, LLC
- Ethicon Endo-Surgery
- Janssen Pharmaceutica N.V., Belgium
- Janssen-Cilag International NV
- Janssen Biotech, Inc.
- Teva Branded Pharmaceutical Products R&D LLC
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Institute of Cancer Research, United Kingdom and peer observational records
Get new ClinicalTrialStartPulse records like Institute of Cancer Research, United Kingdom by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.